CLINICAL_TRIALS trial_result · 2021-12-23

Clinical Trial Update: A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis [Phase 2]

Phase 2 trial update evaluating HP-5000 for efficacy and safety in knee osteoarthritis has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Noven Pharmaceuticals, Inc. | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2021-12-23